Kawarazin ameliorates Beclin1-induced pulmonary fibrosis by increasing miR-193a expression and inhibiting PI3K/Akt/mTOR signaling, thereby increasing autophagy in lung cells (Liu et al., 2019). Here, AKT1 is linked to pulmonary fibrosis.